...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining.
【24h】

Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining.

机译:Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining.

获取原文
获取原文并翻译 | 示例
           

摘要

Carriers of BRCA2 germline mutations are at high risk to develop early-onset breast cancer. The underlying mechanisms of how BRCA2 inactivation predisposes to malignant transformation have not been established. Here, we provide direct functional evidence that human BRCA2 promotes homologous recombination (HR), which comprises one major pathway of DNA double-strand break repair. We found that up-regulated HR after transfection of wild-type (wt) BRCA2 into a human tumor line with mutant BRCA2 was linked to increased radioresistance. In addition, BRCA2-mediated enhancement of HR depended on the interaction with Rad51. In contrast to the tumor suppressor BRCA1, which is involved in multiple DNA repair pathways, BRCA2 status had no impact on the other principal double-strand break repair pathway, nonhomologous end joining. Thus, there exists a specific regulation of HR by BRCA2, which may function to maintain genomic integrity and suppress tumor development in proliferating cells.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号